Category: CovidienSyndicate content

Appeals court vacates $177m Covidien award in spat with J&J

December 4, 2014 by Brad Perriello

A federal appeals court vacates the $177 million in damages awarded to Covidien in its long-running patent infringement war with Johnson & Johnson's Ethicon End-Surgery unit over ultrasound shears technology.

Appeals court vacates $177m Covidien win over Ethicon

UPDATED Dec. 4, 2014, with comment from Covidien and Johnson & Johnson.

Speculation mounts about possible Stryker offer for Smith & Nephew | Medtech Wall Street news for the week of December 1, 2014

December 4, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Stryker bid on Smith & Nephew this week?; Medtronic expects to free up to $4B after IRS beef is settled; Second Sight CEO Greenberg: Next-gen 'bionic eye' could treat nearly all forms of blindness; HCA hospitals halt use of uterine fibroid surgical tool

Will Stryker bid on Smith & Nephew this week?

November 24, 2014 by Brad Perriello

China, South Korea OK Medtronic's $43B Covidien buy

December 4, 2014 by Mark Hollmer

Chinese and South Korean regulators approve the planned $43 billion merger between medical device giants Medtronic and Covidien.

China, South Korea OK Medtronic's $43B Covidien buy

U.S. Federal Trade Commission approves Medtronic, Covidien merger | The week in medtech M&A

December 3, 2014 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: FTC gives Medtronic, Covidien merger the green light; EU regulators clear Medtronic's Covidien buy; Medtronic prices $17B debt offering for Covidien buy

FTC gives Medtronic, Covidien merger the green light

November 26, 2014 by Brian Johnson

Medtronic prices $17B debt offering for Covidien buy

December 1, 2014 by Brad Perriello

Medtronic says it priced $17 billion in a 7-tranche offering of senior notes worth a collective $17 billion, to help fund its $43 billion acquisition of Covidien.

Medtronic prices $17B debt offering for Covidien buy

EU regulators clear Medtronic's Covidien buy

December 1, 2014 by Brad Perriello

Anti-trust regulators in Europe clear Medtronic's $43 billion acquisition of Covidien.

EU regulators clear Medtronic's Covidien buy

FTC gives Medtronic, Covidien merger the green light

November 26, 2014 by Brian Johnson

The U.S. Federal Trade Commission has approved the pending $43 billion merger between Medtronic  and Covidien, according to regulatory filings.

Report: Medtronic readies $10B bond flotation for Covidien deal